Tuesday, June 1, 2010

Brokerage Firm Ratings+Price Target

Updated 01-Jun-10 12:08 ET
CompanyTickerBrokerage FirmRatings ChangePrice Target
Kaiser AlumKALUUBSNeutral » Buy$41 » $44
Alon USA EnergyALJCaris & CompanyBelow Average » Average$6.75
Frontier OilFTOCaris & CompanyBelow Average » Average$10 » $14
HollyHOCCaris & CompanyBelow Average » Average$25 » $27
TesoroTSOCaris & CompanyBelow Average » Average$12.50
Valero EnergyVLOCaris & CompanyBelow Average » Average$14 » $18
SunocoSUNCaris & CompanyBelow Average » Average$28
VisaVStifel NicolausHold » Buy$86
Coca-Cola EntCCEStifel NicolausHold » Buy$30
AOLAOLThe Benchmark CompanyHold » Buy$25
Priceline.comPCLNKeyBanc Capital MktsHold » Buy$260

CompanyTickerBrokerage FirmRatings ChangePrice Target
American EagleAEOCaris & CompanyBuy » Above Average$23 » $20
National GridNGGHSBC SecuritiesOverweight » Neutral
Transdigm GroupTDGOppenheimerOutperform » Perform
GoodrichGROppenheimerOutperform » Perform

CompanyTickerBrokerage FirmRatings ChangePrice Target
Seadrill LtdSDRLBarclays CapitalOverweight$27
Global GeophysicalGGSBarclays CapitalOverweight$19
Mitel NetworksMITLUBSBuy$14
Signature BankSBNYStandpoint ResearchBuy$48
THL CreditTCRDBB&T Capital MktsBuy$15
Finish LineFINLPhoenix Partners GroupBuy$22
China Marine FoodCMFOBrean MurrayBuy$9
THL CreditTCRDStifel NicolausBuy$14
DynaVoxDVOXJefferiesBuy$18

Coverage Reit/Price Tgt Changed*


CompanyTickerBrokerage FirmRatings ChangePrice Target
AppleAAPLUBSBuy$315 » $320
AppleAAPLBroadpoint AmTechBuy$320 » $340
DJSP EnterprisesDJSPNorthland SecuritiesOutperform$16.25 » $10
Altisource Portfolio SolutionsASPSNorthland SecuritiesOutperform$28 » $32
AutoZoneAZOMorgan JosephBuy$186 » $215

The U.S. Economic Collapse Top 20 Countdown

usflag_medWe have taken the greatest free enterprise economy that was ever created and have turned it into a gigantic house of cards delicately balanced on a never-ending spiral of paper money and debt. For decades, all of this paper money and debt has enabled us to enjoy the greatest party in the history of the world, but now the bills are coming due and the party is nearly over.

In fact, things are already so bad that you can pick almost every number and find a corresponding statistic that shows just how bad the economy is getting.

You doubt it?

Well, check this out….

20 – Gallup’s measure of underemployment hit 20.0% on March 15th. That was up from 19.7% two weeks earlier and 19.5% at the start of the year.

19 - According to RealtyTrac, foreclosure filings were reported on 367,056 properties in the month of March. This was an increase of almost 19 percent from February, and it was the highest monthly total since RealtyTrac began issuing its report back in January 2005.

18 – According to the Bureau of Labor Statistics, in March the national rate of unemployment in the United States was 9.7%, but for Americans younger than 25 it was well above 18 percent.

17 – The FDIC’s list of problem banks recently hit a 17-year high.

16 – During the first quarter of 2010, the total number of loans that are at least three months past due in the United States increased for the 16th consecutive quarter.

15 – The Spanish government has just approved a 15 billion euro austerity plan.

14 – The U.S. Congress recently approved an increase in the debt cap of the U.S. government to over 14 trillion dollars.

13 – The FDIC is backing 8,000 banks that have a total of $13 trillion in assets with a deposit insurance fund that is basically flat broke. In fact, the FDIC’s deposit insurance fund now has negative 20.7 billion dollars in it, which actually represents a slight improvement from the end of 2009.

12 – The U.S. national debt soared from the $12 trillion mark to the $13 trillion mark in a frighteningly short period of time.

11- It is being reported that a massive network of big banks and financial institutions have been involved in blatant bid-rigging fraud that cost taxpayers across the U.S. billions of dollars. The U.S. Justice Department is charging that financial advisers to municipalities colluded with Bank of America, Citigroup, JPMorgan Chase, Lehman Brothers, Wachovia and 11 other banks in a conspiracy to rig bids on municipal financial instruments.

10 – The Mortgage Bankers Association recently announced that more than 10 percent of all U.S. homeowners with a mortgage had missed at least one payment during the January-March time period. That was a record highand up from 9.1 percent a year ago.

9 – The official U.S. unemployment number is 9.9%, although the truth is that many economists consider the true unemployment rate to be much, much higher than that.

8 - The French government says that its deficit will increase to 8 percent of GDP in 2010, but by implementing substantial budget cuts they hope that they can get it to within the European Union’s 3 percent limit by the year 2013.

7 – The biggest banks in the U.S. cut their collective small business lending balance by another $1 billion in November. That drop was the seventh monthly decline in a row.

6 – The six biggest banks in the United States now possess assets equivalent to 60 percent of America’s gross national product.

5 – That is the number of U.S. banks that federal regulators closed on Friday. That brings that total number of banks that have been shut down this year in the United States to a total of 78.

4 – According to a study published by Texas A&M University Press, the four biggest industries in the Gulf of Mexico region are oil, tourism, fishing and shipping. Together, those four industries account for approximately $234 billion in economic activity each year. Now those four industries have been absolutely decimated by the Gulf of Mexico oil spill and will probably not fully recover for years, if not decades.

3 – Decent three bedroom homes in the city of Detroit can be bought for $10,000, but no one wants to buy them.

2 - A massive “second wave” of adjustable rate mortgages is scheduled to reset over the next two to three years. If this second wave is anything like the first wave, the U.S. housing market is about to be absolutely crushed.

1 - The bottom 40 percent of all income earners in the United States now collectively own less than 1 percent of the nation’s wealth. But of course many on Wall Street and in the government would argue that there is nothing wrong with an economy where nearly half the people are dividing up 1 percent of the benefits.

Written by The Economic Collapse Blog

European close: US provides late boost

Date: Tuesday 01 Jun 2010
Europe’s top stocks closed slightly higher, with only the French CAC posting a small loss, thanks to better than expected US economic data.

Forecast-beating readings on US construction spending and manufacturing lifted investor sentiment late in the session.

On the downside, the ongoing Mexican Gulf oil leak saga sent
BP sharply lower again.

BP is suffering more woe as attention focuses on the future of chief executive Tony Hayward, with the US government increasingly frustrated by BP's failure to cap the leak. The cost of the clean-up has now reached $1bn, BP added in its latest update.

Across the markets, the Dax in Frankfurt closed 17 points higher at 5,981, the Cac in Paris dropped 4 points to 3,503. The Swiss market gained 4 points to 6,317.

Banks were also weak after the European Central Bank warned that lenders in the eurozone could face up to €195bn in a second wave of potential loan losses over the next 18 months.

The region’s banks may see €90bn of net write-downs on loans and securities this year, and €105bin in 2011, the ECB said in its biannual Financial Stability Report on Monday.

Societe Generale, Credit Agricole, Commerzbank and UBS were all among the worst performers.

Irish no-frills airline
Ryanair swung strongly back into the black last year and proposed a €500m special dividend with the possibility of another €500m in three years time.

Chief executive Michael O'Leary, who owns about 4% of Ryanair's shares, will walk away with a €20m dividend payout.

On the economic front, the eurozone unemployment rate has risen to its highest level in almost 12 years. The unemployment rate across the 16 countries that share the euro rose to 10.1% in April from 10% in March, according to European Union statistics office Eurostat.

The number of jobless rose 25,000, the smallest monthly increase since last November, bringing the total number to 15.9m.


CAC 40 - Risers
Air Liquide (AI) € 81.00 +1.49%
Cap Gemini (CAP) € 37.10 +1.46%
Carrefour (CA) € 34.08 +1.10%
Suez Environnement Company (SEV) € 14.15 +1.07%
GDF Suez (GSZ) € 25.45 +0.75%
L'Oreal (OR) € 76.85 +0.63%
Bouygues (EN) € 35.03 +0.53%
Veolia Environnement (VIE) € 21.06 +0.53%
EDF (EDF) € 35.97 +0.49%
Schneider Electric (SU) € 82.39 +0.49%

CAC 40 - Fallers
Vallourec (VK) € 146.70 -3.58%
ArcelorMittal SA (MT) € 24.20 -2.77%
Societe Generale (GLE) € 34.08 -2.77%
Credit Agricole (ACA) € 8.67 -2.33%
Technip (TEC) € 51.75 -2.21%
Renault (RNO) € 28.79 -2.02%
ST Microelectronics (STM) € 6.32 -1.62%
EADS (EAD) € 16.07 -1.38%
AXA (CS) € 13.28 -1.30%
Alstom (ALO) € 38.73 -1.02%

HOT STOCKS - SRGL, TGGI, SSPT





SRGL - Momentum
The Company's corporate philosophy is to build shareholder value through the exploration and development of high quality mining and exploration projects in Canada, concentrating on gold in the prolific Beardmore-Geraldton Gold Camp in North Western Ontario.


TGGI - Volume Alert
TGGI will continue to acquire and align itself with companies that will add value to shareholders and that are able to operate independently with little to no cash requirements



SSPT - Trade Alert
Shot Spirits Corporation has operations through its two wholly owned subsidiaries, GuestMetrics, Inc and Shot Spirits International.

Blinkx SPECULATIVE BUY !!!

Video search engine company Blinkx narrowed its losses in the year to March to US$8.9m (£6.2m), as revenue rose to $33.6m (£23.4).

Founder and CEO Suranga Chandratillake was ebullient following the results, tellingGrowth Company Investor that 'together with a 140% increase in revenue, the (swing to) positive EBITDA figures has reduced our risk’. Blinkx, floated on AIM in 2007 with a £25m funding at 45p, enables users of its site to search across a variety of video hosting websites such as Youtube, Myspace and Metacafe. In fact, Chandratillake describes Blinkx as being like a ‘remote control for online tv’.

He believes Blinkx, with $14.6m (£10m) cash, is poised for great things as the large video content market develops, arguing that ‘there is no market with more potential than online video advertising. Advertising budgets are going to shift from television to online content.’

Broker Piper Jaffray predicts revenues should grow by 33% to $40.1m (£27.6m) in the year to March 2011, although Blinkx is not forecast to make a profit until 2012, when analysts see a pre-tax $2.9m (£2m) as achievable. Whilst Blinkx is operating in a highly competitive environment in which it is seeking to win market share from established names such as Youtube and Google, we think the shares represent a risky, but potentially hugely rewarding punt.

http://www.blinkx.com/

http://www.google.com/finance?q=LON:BLNX

PHARMAGAP ANNOUNCES APPOINTMENT TO CLINICAL DEVELOPMENT GROUP; SEARCH FOR CHIEF OPERATING OFFICER TO GUIDE LEAD DRUG TO CLINICAL TRIALS

PharmaGap
Marketwire.com - Jun 1, 2010

OTTAWA, ONTARIO--(Marketwire - June 1, 2010) - PharmaGap Inc. (TSX VENTURE:GAP) (OTCBB:PHRGF) ("PharmaGap" or "the Company") today announced the appointment of Dr. Kenneth K. Sokoll, PhD., to the Company's Clinical Development Group ("CDG"). Dr. Sokoll has extensive hands-on experience in the planning, management, oversight, and delivery of programs to take preclinical drug compounds into and through human clinical trials. The Company also reported that it is actively seeking an experienced drug development executive to assume the key role of Chief Operating Officer as its lead cancer drug GAP-107B8 progresses to Clinical Trials.

Dr. Sokoll stated that "I am very excited about PharmaGap's drug program, and look forward to being a key part of the program at this very critical juncture. I am especially keen to be involved with a Canadian company, in my own backyard, and am pleased to have been invited to join the PharmaGap team."

Dr. Sokoll has served in an executive role in the drug development industry since 2003, and has served in a variety of product development roles since 1994 in Canada, the U.S., and France. He has assumed full responsibility for clinical trials, clinical trial protocol development and delivery, as well as development of strategies for clinical development of lead drug candidates, preclinical development, and chemistry, manufacturing and control (CMC) requirements, among others.

Robert McInnis, President and Chief Operating Officer, commented "We are thrilled to be able to find a drug developer with Dr. Sokoll's background and experience in the Ottawa area, to take hands-on direction of our program toward clinical trials for GAP-107B8. The Company is now at the stage where experience in delivering the vast amount of detail required to gain approval for clinical trials and to be able to direct the Company's effort in this regard is most needed, and the addition of Dr. Sokoll to our team is most welcome. I would like to thank our current Chief Operating Officer, Simon Goulet, who will be leaving the Company, for his efforts in helping us bring the company to where we are today. The continued and accelerating evolution of the Company toward Clinical Trials now demands a different set of skills and experience in this important role to move the Company forward."

Rod Bryden, Chairman of the Company and Chairman of SC Stormont Holdings Inc. ("Stormont"), the Company's largest shareholder, said "These actions are important steps in the development of PharmaGap. As previously announced Stormont is exercising warrants with an exercise price of just over twenty cents a share and will exercise these warrants in a series of elections over the coming weeks to continue to support the Company in funding its operations. Stormont currently holds a total of 2,265,359 of these warrants. I am glad to be able to take this opportunity to add to Stormont's investment in PharmaGap, which I see as a long term position for us."

About PharmaGap Inc.

PharmaGap Inc. (TSX VENTURE:GAP), based in Ottawa, ON, is a biotechnology company with a core focus on developing novel peptide therapeutics for the treatment of cancer. PharmaGap's GAP-107B8 is a novel peptide drug that has been shown to be highly cytotoxic to numerous cancer types, including chemo-resistant cancers, in vitro. For more information on PharmaGap please visit the Company's website at www.pharmagap.com.

Note: The TSX-Venture Exchange does not accept responsibility for the adequacy or accuracy of this release. No Securities Commission or other regulatory authority having jurisdiction over PharmaGap has approved or disapproved of the information contained herein. This release contains forward looking statements that may not occur or may change materially.

http://www.pharmagap.com/

http://www.google.com/finance?q=CVE:GAP

Daily News and Research on Chinese Stocks (May 31, 2010)

AMCN: AirMedia Announces 20-F Filing - PR Newswire (Mon 6:00am)

ASIA BIDU CVVT: [video] Playing on Shaky Ground: China Watch - at TheStreet.com (Mon 6:00am)

BIDU: [$$] The Worst May in a Half-Century - at Barron's Online (Sat, May 29)

CAAS FEED SEED SOLF SORL WATG: Thunderous Week for Emerging Market ADRs - at TheStreet.com (Fri, May 28)

CEO PTR SNP: China lifts natgas prices in long-awaited reform- at Reuters (Mon 9:20am)

DEER JST NIV: The Best Stocks for the Next 4 Years - at Motley Fool (Fri, May 28)

FFHL: Fuwei Films Announces Unaudited Financial Results for the First Quarter of 2010 - PR Newswire (Fri, May 28)

HOLI: Hollysys Automation Technologies Appoints New Board Chairman - PR Newswire (Mon 8:00am)

JASO: Barclays Sees Little Shine For JA Solar - at Forbes (Fri, May 28)

JASO: [video] Downgrades: MON, JASO, BCSI - at Forbes.com (Fri, May 28)

JASO: JA Solar downgraded by Barclays Capital - Briefing.com (Fri, May 28)

LFC: [video] Under the Radar - at CNBC (Fri, May 28)

MPEL: A Big Upgrade for International Game Technology - at Motley Fool (Fri, May 28)

PSOF PTR SHI: [video] Pansoft: China Watch - at TheStreet.com (Sun 9:00pm)

RINO: 3 Top Stocks at Half Price - at Motley Fool (Fri, May 28)

SEED: Target And Wal-Mart Get Tandem Praise - at Forbes (Fri, May 28)

SNDA: Trading Radar: Stock Action Tied to Global Events - at Minyanville (Fri, May 28)

SOHU: VivaKi Brings Online Video Research Project To China - paidContent.org (Fri, May 28)

TSL: Fearful Stocks for Greedy Investors - at Motley Fool (Fri, May 28)

VIT: Top Stocks Move In Quiet Trading Ahead Of Holiday - at Investor's Business Daily (Fri, May 28)

XIN: Friday Gains Tough To Come By, But Xinyuan Rallies - at Forbes (Fri, May 28)

XIN: [video] Today's Big Gainers: XIN, NX, CKXE, HEV - at Forbes.com (Fri, May 28)

XIN: CKX, DJSP Enterprises: Midday Volume Plays - at TheStreet.com (Fri, May 28)

Top 10 Best-Rated Medical Equipment Stocks: STJ, COV, MDT, NUVA, SIRO, MR, EW, TMO, THOR, ZMH (Jun 01, 2010)

Posted: 01 Jun 2010 07:59 AM PDT

St. Jude Medical, Inc. (NYSE:STJ) is the 1st best-rated stock in this segment of the market. It is rated positively by 20 brokerage analysts. It is covered by 20 brokerage analysts. Covidien plc (NYSE:COV) is the 2nd best-rated stock in this segment of the market. It is rated positively by 16 brokerage analysts. It is covered by 16 brokerage analysts. Medtronic, Inc. (NYSE:MDT) is the 3rd best-rated stock in this segment of the market. It is rated positively by 16 brokerage analysts. It is covered by 16 brokerage analysts. NuVasive, Inc. (NASDAQ:NUVA) is the 4th best-rated stock in this segment of the market. It is rated positively by 15 brokerage analysts. It is covered by 15 brokerage analysts. Sirona Dental Systems, Inc. (NASDAQ:SIRO) is the 5th best-rated stock in this segment of the market. It is rated positively by 13 brokerage analysts. It is covered by 13 brokerage analysts.

Mindray Medical International Limited (NYSE:MR) is the 6th best-rated stock in this segment of the market. It is rated positively by 13 brokerage analysts. It is covered by 13 brokerage analysts. Edwards Lifesciences Corp (NYSE:EW) is the 7th best-rated stock in this segment of the market. It is rated positively by 13 brokerage analysts. It is covered by 13 brokerage analysts. Thermo Fisher Scientific Inc. (NYSE:TMO) is the 8th best-rated stock in this segment of the market. It is rated positively by 12 brokerage analysts. It is covered by 12 brokerage analysts. Thoratec Corporation (NASDAQ:THOR) is the 9th best-rated stock in this segment of the market. It is rated positively by 12 brokerage analysts. It is covered by 12 brokerage analysts. Zimmer Holdings, Inc. (NYSE:ZMH) is the 10th best-rated stock in this segment of the market. It is rated positively by 12 brokerage analysts. It is covered by 12 brokerage analysts.